Journal of Dentistry Indonesia
Volume 22
Number 3 December

Article 5

12-30-2015

Oral Lichen Planus: Diagnosis and Management
Isaäc van der Waal
Department of Oral and Maxillofacial Surgery and Oral Pathology of the ACTA/ VU University Medical
Center, Amsterdam, The Netherlands, i.vanderwaal@vumc.nl

Follow this and additional works at: https://scholarhub.ui.ac.id/jdi

Recommended Citation
Waal, I. v. Oral Lichen Planus: Diagnosis and Management. J Dent Indones. 2015;22(3):

This Literature Review is brought to you for free and open access by the Faculty of Dentistry at UI Scholars Hub. It
has been accepted for inclusion in Journal of Dentistry Indonesia by an authorized editor of UI Scholars Hub.

Journal of Dentistry Indonesia 2015, Vol. 22, No. 3, 89-92
doi:10.14693/jdi.v22i3.979

LITERATURE REVIEW

Oral Lichen Planus: Diagnosis and Management
Isaäc van der Waal
Department of Oral and Maxillofacial Surgery and Oral Pathology of the ACTA/ VU University Medical Center,
Amsterdam, The Netherlands
Correspondence e-mail to: i.vanderwaal@vumc.nl

ABSTRACT
Oral lichen planus (OLP) is a rather common oral disease, mainly affecting adults, occurring more often in women
than in men. The etiopathogenesis is still unclear. The diagnosis may be cumbersome, even in the presence of a
biopsy. In addition, there are several lesions that may resemble lichen planus (lichenoid lesions) both clinically
and histopathologically. Treatment of OLP can only be symptomatic and usually consists of topical application
of corticosteroids. The disease is characterized by remissions and exacerbations and may persist in some patients
lifelong. There is an ongoing debate in the literature as whether OLP is a potentially malignant disease. Because
of this uncertainty, annual follow-up is advised.
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INTRODUCTION
Lichen planus (LP) is a chronic mucocutaneous
disorder which may involve the oral mucosa only
(“isolated OLP”) or in combination with involvement
of other mucosal surfaces, e.g. vagina (“vulvovaginalgingival syndrome”), oesophagus, pharynx, and nails.
It has been suggested that extra-oral involvement in oral
lichen planus is more common than suspected.1,2 A few
cases have been reported of transformation of OLP into
mucous membrane pemphigoid, being referred to as
lichen planus pemphigoides.3 Attention will be paid at
the diagnostic aspects of OLP and lichenoid lesions, as
well at the various treatment modalities. An important
question whether OLP is a benign lesion or a potentially
malignant one.
Epidemiology
The estimated prevalence of oral lichen planus is
approximately 0.1 %, although figures varying from
1% to 4% have been reported in the literature.4 Oral
lichen planus mainly affects middle-aged people and
is more common among women than among men.5
Familial presentation is extremely rare.6 Oral lichen
planus occurs mainly in non-smokers.7 Little is known
about possible geographic differences.

Etiology
Lichen planus is most likely caused by T- cell autoimmunity. Apparently, Langerhans cells play an important role in
this process.8 Controversial views have been reported about
the role of human papilloma virus (HPV), particularly
HPV 16.9,10 There is no evidence that psychological factors
are a direct etiological factor. In some populations there is
a significant, yet unexplained, association between lichen
planus and hepatitis C virus.11 Yet, in other populations an
association with thyroid diseases, especially hypothyroidism, has been reported.12
Lichen planus or lichen planus-like lesions, usually
referred to as lichenoid lesions or lichenoid reactions,
may occasionally be caused by certain drugs.13 Also
prolonged, direct anatomic contact with large amalgam
restorations (“contact lesion”) may produce a lichenoid
appearance of the oral mucosa. Furthermore, a chronic
graft versus host reaction after an allogenic stem cell
transplantation may strongly resemble OLP. Interestingly,
the lower lip is a site of predilection in this particular
patient population.
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Clinical aspects
Signs and symptoms
Oral lichen planus has various clinical manifestations,
such as reticular (characterized by white striae, also
referred to as “Wickhams striae”), annular, papular,
erythematous, plaque- type, ulcerative and bullous
type. The reticular, the erythematous and the plaque
types are the most common ones. The various types
may occur simultaneously in an individual patient and
may also change in time. (Figure. 1 and 2). It has been
suggested that the plaque type is more common among
smokers. There is nearly always a bilateral, more or
less symmetrical distribution. The buccal mucosa, the
gingiva and the dorsal surface of the tongue are the
sites of predilection. Occurrence in the floor of the
mouth and the palate is rare. Superficial mucoceles
may develop within or adjacent to mucosal areas that
are involved by lichen planus, while in dark-skinned
people post-inflammatory melanosis has been reported
to occur in the affected areas.

(a)

(b)

(c)

(d)

Figure 1. A 55-year-old woman with plaque-type OLP of the
tongue (a), erythematous type of the gums (b) and reticular
type on the buccal mucosa (c and d).

Par ticularly the er ythematous type may cause
symptoms, such as pain and, in case of gingival
involvement, severe bleeding during toothbrushing.
Patients affected by the erythematous or ulcerative
type of OLP usually do not tolerate spicy food. When
the gums are involved patients may complain about
the esthetic aspect of their gums. In involvement of
the gingiva the presence of the “vulvovaginal gingiva
syndrome” should be considered.

(a)

(b)

Figure 2. A 58-year-old woman with a somewhat plaque-type
OLP at the lateral border of the tongue (a); after six weeks
there is a distinct reticular pattern (b).

Box 1. Drugs possibly causing lichenoid lesions13
Antihypertensives (e.g. ACE inhibitors)
Oral hypoglycaemics (e.g. Tolbutamide)
Non-steroidal anti-inflammatory drugs
Second line anti-arthritics (gold; penicillamine)
Xanthine oxidase inhibitors (Allopurinol)
Psychoactive drugs (e.g. tricyclic antidepressants)
Diuretics (e.g. furosamide)
Antiparasitic drugs
A ntimicrobial agents,including mouth r inses (e.g.
tetracycline)
Miscellaneous drugs (e.g. iodides, quinidine)

The course of oral lichen planus is characterized by
remissions and exacerbations with intervals of several
weeks or months of both the clinical signs and the
symptoms. There are various scoring systems, mainly
designed for scientific studies, to quantify the clinical
signs and symptoms of OLP.14
Clinical differential diagnosis, including lichenoid
lesions
Llichenoid lesions may be caused by direct anatomic
contact with a large (amalgam) restoration. Replacement
of the restoration should result in healing of the lesion
within several weeks, but this should be checked by
the clinician. One may consider to take a biopsy before
advising to have the amalgam restoration removed in
order to exclude the possibility of a dysplastic or even a
malignant lesion. The predictive value of epicutaneous
patch testing for amalgam and mercury allergy is rather
questionable.15,16 In contrast todrug-induced cutaneous
lichenoid lesions drug-induced oral lichenoid lesions
are extremely rare. Nevertheless, one may consider to
adjust the medication (Box 1), if applicable. Of course,
such adjustment requires communication with the
prescribing specialist.

times, it may be difficult, if not impossible, to clinically
distinguish oral lichen planus not only from lichenoid
lesions but also from leukoplakia, lupus erythematodes,
linear IgA disease, mucous membrane pemphigoid and
some other white or red lesions of the oral mucosa.17 In
some of these cases the medical history or other clinical
features are helpful in establishing the correct diagnosis.
Unfortunately, a biopsy is not always helpful in such
cases. Some clinicians will always do a biopsy in case
of oral lichen planus, while others take a biopsy only
in case of doubt about the diagnosis.
Histopathology
In case of a distinct clinical diagnosis of lichen planus the
histopathologic features are usually quite characteristic
(Figure 3.). In scientific studies usually reference is made

As has been mentioned already, lichenoid lesions may
occur in chronic graft-versus-host disease, being clinically
sometimes indistinguishable from “idiopathic” OLP. At
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Is oral lichen planus potentially malignant and can
such event be prevented?
Oral lichen planus is by some regarded as a premalignant
condition, the annual malignant transformation rate
being less than 1%.21 If this event occurs, it usually
concerns the tongue.6 The suggestion has been made
that a certain cell surface marker on hematopoietic stem
cells and early progenitor cells in the bone marrow,
referred to as CD133, correlates with the progression
to oral squamous cell carcinoma.22

Figure 3. Low power view, rather suggestive of lichen planus
(H-E; original magnification. X100).

Figure 4. Severe epithelial dysplasia in a biopsy taken from
a leukoplakia (H-E; original magnification X100). The
bandlike subepithelial infiltrate is somewhat suggestive of
OLP; hence the rather confusing term “lichenoid dysplasia”

to a definition study from the World Health Organization,
published in 1978.18 However, these histologic criteria
have not been validated. In another study it has been
shown that there is no good correlation between the
clinical diagnosis and the histopathologic diagnosis of
OLP.19 It is, indeed, hardly justified to arrive at a firm
diagnosis of OLP based on histopathologic examination
only. Furthermore, there are opposing views of the possibility
to histopathologically distinguish lichen planus from the
various lichenoid lesions.20
Epithelial dysplasia is by most pathologists not accepted
as compatible with a histopathologic diagnosis of lichen
planus. Some pathologists use the term “lichenoid
dysplasia” when reporting on leukoplakic lesions that
show a subepithelial bandlike lymphocytic infiltrate
in the presence of epithelial dysplasia (Figure 4.). The
use of this term may erroneously be interpreted by the
clinician as the presence of dysplastic changes in lichen
planus. Lichen planus does not show characteristic
feat u res on im mu nof luorescent examination;
nevertheless, such examination may be helpful to
distinguish lichen planus from vesiculobullous diseases
such as mucous membrane pemphigoid.

Others have not found any evidence for a potentially
malignant behavior. 23 Anyhow, such malignant
transformation can not be prevented, although it has
been speculated that the use of topical steroids may
prevent such event.24
Treatment
Oral lichen planus may last for many years, if not
lifelong.25 There is no cure for oral lichen planus.
Treatment can only be symptomatic and most
commonly consists of topical or, occasionally systemic,
corticosteroids. The use of corticosteroids may enhance
the risk of the development of candidiasis, sometimes
necessitating antimycotic therapy.
Also the use of many other drugs, e.g. tacrolimus,
thalidomide, topical aloe vera, oral curcuminoids and
lysopine has been reported.26 The efficacy of all these
drugs is rather questionable.27 There are opposing views
about the effect of removing all amalgam restorations,
not just the ones directly related to a lesion.28,29 It has
been shown that plaque control improves the symptoms
of OLP with gingival involvement.30
A variety of other treatment modalities has been
reported, such as surgical excision, laser evaporation,
laser excision and photodynamic treatment. Such
treatment modalities may be useful in persistent
localized areas of lichenoid involvement.
Follow-up
Since the issue of premalignancy is still under debate, it
seems safe practice to check the patient annually for any
possible unfavorable change. However, it is questionable
whether such follow-up is really effective in either
preventing malignant transformation or in resulting in
better survival in case of cancer development.
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